Clinical Trial Update: Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis [Phase 3]

View source ↗

Summary

Phase 3 study evaluating batoclimab for induction and maintenance therapy in adults with generalized myasthenia gravis. The trial is currently active but not re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Myasthenia Gravis

Drugs mentioned

• Batoclimab (batoclimab)

Snippet

Sponsor: Immunovant Sciences GmbH | Conditions: Generalized Myasthenia Gravis | Phase 3 | Status: ACTIVE_NOT_RECRUITING